Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Aroa Biosurgery shares have surged on the back of full-year results that exceeded guidance and restored the company to ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

GSK is preparing to present data from its respiratory portfolio in more than 40 abstracts at the 2025 edition of the American Thoracic Society (ATS) International Congress, which will be held in San ...

The deadline to submit abstracts for scientific posters for the IAEA’s International Conference ... The latest research shows that about 4.2 billion medical radiological examinations are performed ...

To submit your poster abstract, visit alfc2025.com. About the Advanced Lateral Flow Conference The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for ...

April 24, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that ...